Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2019-12-24 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
第四届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution from the first meeting of the fourth Supervisory Board of the company, including the election of the Supervisory Board Chairman. It details the meeting attendance, voting results, and includes a biography of the elected chairman. There are no financial statements, earnings data, or regulatory filings related to financial performance. The content focuses on board/management changes, specifically the election of a new Supervisory Board Chairman. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a certification, so it is not RPA or RNS. Hence, the classification is MANG with high confidence.
2019-12-24 Chinese
独立董事关于公司第四届董事会第一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on the appointment of senior management at the company's fourth board meeting. It references compliance with company law, stock exchange rules, and company articles, and confirms the qualifications and appointment of specific senior executives. The document is a formal statement related to board/management changes rather than a full report or announcement of financial results. It does not contain financial data or earnings information, nor is it a regulatory filing or announcement of a report publication. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2019-12-24 Chinese
第四届董事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the first meeting of the fourth board of directors of 三诺生物传感股份有限公司 (Sinocare Inc.). It includes information about the election of the chairman, appointment of various board committees, and appointments of senior management positions such as general manager, deputy general manager, financial director, board secretary, and securities affairs representative. The document also provides biographies of the appointed individuals and confirms compliance with relevant laws and regulations. There is no financial data or quarterly/annual report content. The document is clearly an announcement related to changes in the company's board and senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length (8006 characters) and content confirm it is not a brief announcement or a report publication announcement but a substantive announcement of management changes.
2019-12-24 Chinese
关于公司董事会、监事会完成换届选举暨部分董事离任的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the completion of the board of directors and supervisory board re-election, including details about new board members and some directors leaving their positions. It contains no financial data or report content but focuses on management changes. The document is titled as an announcement and includes compliance statements about the qualifications of the new board members. This fits the category of Board/Management Information (MANG). The document length is short and it is not a report or financial statement, so it is not an Annual Report or Interim Report. Therefore, the correct classification is MANG with high confidence.
2019-12-23 Chinese
2019年第二次临时股东大会的法律意见书
Regulatory Filings
2019-12-23 Chinese
2019年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2019 second extraordinary general meeting of shareholders of 三诺生物传感股份有限公司. It includes information about the meeting date, voting methods, attendance, and detailed voting results for various board and supervisory committee elections and other proposals. The document also mentions the legal opinion confirming the validity of the meeting and voting procedures. There is no financial data or report content, but rather the official results of shareholder votes at a general meeting. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is under 5,000 characters, but it contains substantive voting results, not just a brief announcement or a link to a report, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is DVA with high confidence.
2019-12-23 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.